Clinical Trial Update: Azacitidine and Lenalidomide for Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion and results posting for a Phase 1/2 trial of azacitidine plus lenalidomide in adults with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Revlimid (lenalidomide)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-09-07